Flow path system of ultraviolet C irradiation from xenon flash to reduce bacteria survival in platelet products containing a platelet additive solution

被引:6
作者
Abe, Hideki [1 ]
Endo, Kimika [1 ]
Shiba, Masayuki [1 ]
Niibe, Yoshiyuki [2 ]
Miyata, Shigeki [1 ]
Satake, Masahiro [1 ]
机构
[1] Japanese Red Cross Soc, Blood Serv Headquarters, Cent Blood Inst, Tokyo, Japan
[2] Comet Co LTD, Tokyo, Japan
关键词
IN-VITRO QUALITY; CONTAMINATION; BLOOD; INACTIVATION; STORAGE; PLASMA; LIGHT; COMPONENTS; IMPACT;
D O I
10.1111/trf.15757
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Our previous study showed that ultraviolet C (UVC) from xenon (Xe) flash without any photoreactive compounds inactivated bacteria in platelet concentrates (PCs) with less damage to platelets (PLTs) as compared with Xe flash containing ultraviolet A, ultraviolet B, and visible light. Here, we report a UVC irradiation system for PCs under flow conditions consisting of a flow path-irradiation sheet, a peristaltic pump, and a collection bag. STUDY DESIGN AND METHODS Platelet concentrates containing Ringer & apos;s solution (R-PCs) inoculated with bacteria were injected into a flow path sheet using a peristaltic pump, being irradiated with UVC from Xe flash. The quality of the irradiated PCs containing platelet additive solution (PAS-PCs) was assessed based on PC variables, PLT surface markers, and aggregation ability. RESULTS Streptococcus dysgalactiae (12 tests) and Escherichia coli (11) were all negative on bacterial culture, while Staphylococcus aureus (12) and Klebsiella pneumoniae (14) grew in one and two R-PCs, respectively. Bacillus cereus spores were inactivated in 7 of 12 R-PCs. PC variables became significantly different between irradiated and nonirradiated PAS-PCs. P-selectin, first procaspase-activating compound (PAC-1) binding, and phosphatidylserine increased by irradiation. Aggregability stimulated by adenosine diphosphate, collagen, or thromboxane A(2) increased in the irradiated PAS-PCs, while that by thrombin became smaller compared with nonirradiated controls. CONCLUSION This newly developed system inactivated bacteria including spores in R-PCs. PAS-PCs irradiated by this system retained acceptable in vitro quality and aggregability. Usage of a peristaltic pump instead of agitator during irradiation may enable this system to be directly combined with an apheresis blood cell separator.
引用
收藏
页码:1050 / 1059
页数:10
相关论文
共 32 条
[1]   Altered activation of integrin αIIbβ3 on platelets irradiated with ultraviolet C from pathogen-reducing xenon flash [J].
Abe, Hideki ;
Shiba, Masayuki ;
Satake, Masahiro .
TRANSFUSION AND APHERESIS SCIENCE, 2019, 58 (03) :337-340
[2]   Pulsed xenon flash treatment inactivates bacteria in apheresis platelet concentrates while preserving in vitro quality and functionality [J].
Abe, Hideki ;
Shiba, Masayuki ;
Niibe, Yoshiyuki ;
Tadokoro, Kenji ;
Satake, Masahiro .
TRANSFUSION, 2017, 57 (04) :989-996
[3]   Reduction of bacteria and human immunodeficiency virus Type 1 infectivity of platelet suspension in plasma using xenon flash-pulse light in a bench-scale trial [J].
Abe, Hideki ;
Shiba, Masayuki ;
Niibe, Yoshiyuki ;
Tadokoro, Kenji ;
Satake, Masahiro .
TRANSFUSION, 2016, 56 (09) :2256-2266
[4]   In vitro study of platelet function confirms the contribution of the ultraviolet B (UVB) radiation in the lesions observed in riboflavin/UVB-treated platelet concentrates [J].
Abonnenc, Melanie ;
Sonego, Giona ;
Crettaz, David ;
Aliotta, Alessandro ;
Prudent, Michel ;
Tissot, Jean-Daniel ;
Lion, Niels .
TRANSFUSION, 2015, 55 (09) :2219-2230
[5]  
[Anonymous], 2019, BACT RISK CONTR STRA
[6]  
[Anonymous], 2017, INF CAS WER PROB REL
[7]   Pathogen inactivation of platelets using ultravioletC light: effect on in vitro function and recovery and survival of platelets [J].
Bashir, Saber ;
Cookson, Philip ;
Wiltshire, Michael ;
Hawkins, Louise ;
Sonoda, Luke ;
Thomas, Stephen ;
Seltsam, Axel ;
Tolksdorf, Frank ;
Williamson, Lorna M. ;
Cardigan, Rebecca .
TRANSFUSION, 2013, 53 (05) :990-1000
[8]   Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3-year period [J].
Cazenave, Jean-Pierre ;
Isola, Herve ;
Waller, Chantal ;
Mendel, Isabelle ;
Kientz, Daniel ;
Laforet, Michel ;
Raidot, Jean-Pierre ;
Kandel, Gerard ;
Wiesel, Marie-Louise ;
Corash, Laurence .
TRANSFUSION, 2011, 51 (03) :622-629
[9]   Routine use of Day6 and Day7 platelets with rapid testing: two hospitals assess impact 1year after implementation [J].
Harm, Sarah K. ;
Szczepiorkowski, Zbigniew M. ;
Dunbar, Nancy M. .
TRANSFUSION, 2018, 58 (04) :938-942
[10]   Routine use of a rapid test to detect bacteria at the time of issue for nonleukoreduced, whole bloodderived platelets [J].
Harm, Sarah K. ;
Delaney, Meghan ;
Charapata, Michael ;
AuBuchon, James P. ;
Triulzi, Darrell J. ;
Yazer, Mark H. .
TRANSFUSION, 2013, 53 (04) :843-850